0000000000142278

AUTHOR

J. Sastre

showing 5 related works from this author

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

2016

Background:This single-arm phase II study investigated the EGFR monoclonal antibody necitumumab plus modified FOLFOX6 (mFOLFOX6) in first-line treatment of locally advanced or metastatic colorectal cancer (mCRC).Methods:Patients received 800-mg intravenous necitumumab (day 1; 2-week cycles), followed by oxaliplatin 85 mg m -2, folinic acid 400 mg m -2, and 5-fluorouracil (400 mg m -2 bolus then 2400 mg m -2 over 46 h). Radiographic evaluation was performed every 8 weeks until progression. Primary endpoint was objective response rate.Results:Forty-four patients were enrolled and treated. Objective response rate was 63.6% (95% confidence interval 47.8-77.6); complete response was observed in …

0301 basic medicineMaleCancer ResearchOrganoplatinum CompoundsLeucovorinPhases of clinical researchmedicine.disease_causeGastroenterology0302 clinical medicineadvanced colorectal cancerAntineoplastic Combined Chemotherapy ProtocolsClinical endpointNeoplasm MetastasisNecitumumabModified FOLFOX6Aged 80 and overnecitumumabAntibodies MonoclonalMiddle AgedOxaliplatinTreatment OutcomeOncologyFluorouracil030220 oncology & carcinogenesisFemaleKRASFluorouracilColorectal Neoplasmsmedicine.drugAdultmedicine.medical_specialtyEGFRNeutropeniamodified FOLFOX6Antibodies Monoclonal HumanizedDisease-Free SurvivalProto-Oncogene Proteins p21(ras)03 medical and health sciencesFolinic acidInternal medicinemedicineKRASHumansAdvanced colorectal cancerAgedbusiness.industrymedicine.diseaseSurvival AnalysisSurgeryOxaliplatinCancérologie030104 developmental biologyClinical StudybusinessNecitumumabBritish Journal of Cancer
researchProduct

Significance of gamma-glutamyltranspeptidase in exocrine pancreatic amino acid transport.

1991

The exocrine pancreas is rich in gamma-glutamyltranspeptidase (GGT, EC 2.3.2.2) and exhibits high rates of amino acid transport and protein synthesis. The role of the gamma-glutamyl cycle in mediating neutral amino acid transport in the isolated perfused rat pancreas was investigated using acivicin, an inhibitor of GGT, and a rapid dual isotope dilution technique. When treatment in vivo with acivicin (50 mg/kg) was followed 1 h later by continuous perfusion of the isolated pancreas with 10 microM acivicin, GGT levels decreased from 53 +/- 3 IU/g to 4.9 +/- 1.5 IU/g. This marked inhibition of GGT activity was not associated with decreased uptake for either L-alanine or L-glutamine, suggestin…

Malemedicine.medical_specialtyGlutamineBiophysicsIndicator Dilution TechniquesBiologydigestive systemBiochemistryEpitheliumchemistry.chemical_compoundIn vivoInternal medicineNeutral amino acid transportmedicineAnimalsAmino AcidsAcivicinPancreasEpithelial polaritychemistry.chemical_classificationAlanineBiological TransportRats Inbred StrainsCell BiologyIsoxazolesgamma-Glutamyltransferasedigestive system diseasesEpitheliumAmino acidRatsEnzymemedicine.anatomical_structureEndocrinologychemistryPancreasBiochimica et biophysica acta
researchProduct

Pancreatitis autoinmune: pseudotumor inflamatorio, afectación multifocal, hipertensión portal y evolución a largo plazo

2008

Autoimmune pancreatitis is a recently characterized disease that still constitutes a diagnostic challenge, especially regarding differential diagnosis from neoplasia. Long-term outcome is poorly known. We herein report a case of a patient with autoimmune pancreatitis and 14 years of follow-up, and show its clinical, biochemical, and morphological characteristics. A 54-year-old female presented with obstructive jaundice and abdominal tenderness, as well as a mass at the pancreatic head on a CT scan, suggestive of pancreatic neoplasia. Surgery showed an increase of the whole pancreas, malignancy was intraoperatively ruled out, and a cholecystectomy and choledochoduodenostomy were carried out.…

Pathologymedicine.medical_specialtybusiness.industryGastroenterologyGeneral MedicineJaundicemedicine.diseaseRetroperitoneal fibrosismedicine.anatomical_structureEsophageal varicesmedicinePortal hypertensionPancreatitismedicine.symptomDifferential diagnosisPancreasbusinessAutoimmune pancreatitisRevista Española de Enfermedades Digestivas
researchProduct

Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

2021

n/a

Caratmedicine.medical_specialtybusiness.industryMEDLINESettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseRhinitis AllergicAsthmaTest (assessment)Internal medicineHumansImmunology and AllergyMedicinebusinessRhinitisAsthmaThe Journal of Allergy and Clinical Immunology: In Practice
researchProduct

Utilización de la Transferrina Deficiente en Carbohidratos (CDT) en el diagnóstico y seguimiento de la dependencia alcohólica

2002

Al no contar con una prueba de laboratorio que tenga una fiabilidad absoluta en el diagnostico del alcoholismo y en la evolucion posterior para corroborar el consumo o la abstinencia, se ha recurrido ultimamente a la utilizacion del transferrina deficiente en carbohidratos para acercarnos al diagnostico y a la evolucion en el proceso terapeutico. En la Unidad de Alcohologia del Area de Salud de Alcoi de la Conselleria de Sanitat de la Generalitat Valenciana, venimos utilizando esta prueba de laboratorio desde el ano 1997 hasta la actualidad. Creemos que una vez realizada esta prueba en mas de 400 pacientes ha llegado el momento de realizar un analisis descriptivo y estadistico para poder va…

Psychiatry and Mental healthMedicine (miscellaneous)Adicciones
researchProduct